JPRN-UMIN000000822
Completed
Phase 1
A phase I/IIa study of heat immunotherapy using anti-melanoma antibody conjugated magnetoliposome for advanced melanoma patients - A phase I/IIa study of heat immunotherapy using anti-melanoma antibody conjugated magnetoliposome for advanced melanoma patients
Department of Dermatology, Shinshu University School of Medicine0 sites6 target enrollmentSeptember 7, 2007
Conditionsmelanoma
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- melanoma
- Sponsor
- Department of Dermatology, Shinshu University School of Medicine
- Enrollment
- 6
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. An anti\-cancer therapy has been received within previous 4 weeks 2\. Patients who have brain metastases 3\. Patients who have a life expectancy of less than 6 months 4\. Patients who are pregnant or nursing 5\. Patients who have severe pleural or pericardial effusion or ascites 6\. Patients who have active infection 7\. Patients who have other malignancies 8\. Patients who are unable to keep protocol due to psychiatric, familial, social or traffic disadvantage 9\. Patients who have metals inside the body near (within 10 cm) the lesion where alternative magnetic field is put 10\. Patients who have active asthma, or have had severe anaphylaxis before. 11\. Patients who are judged inappropriate to be enrolled in this study by the doctor in charge
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
A Multi-Center, Randomized Controlled Trial of Heat-Sensitive Moxibustion in the Treatment of Knee OsteoarthritisITMCTR2000003317The Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine
Unknown
Phase 1
Phase I/II study of adoptive immunotherapy using cytotoxic T cells specific for minor histocompatibility antigen restricted to hematopoietic cells for patients with high-risk leukemia that relapsed following allogeneic hematopoietic stem cell transplantatio1) RAEB, CMML 2) AML or ALL in induction failure or beyond first remission 3) Ph/p190-positive ALL at any stage 4) imatinib-resistant CMJPRN-C000000162Aichi Cancer Center30
Completed
Phase 1
Phase I/II Trial of a novel mild hyperthermia using Oncothermia (EHY-2000) and TS-1/Docetaxel in the treatment of peritoneal metastatic gastric cancerGastric cancerJPRN-UMIN000022420Chiba University33
Active, not recruiting
Not Applicable
A Phase I/II Study of Immunotherapy with Subcutaneous Administered Veltuzumab (hA20) in Patients with CD20+ Non-Hodgkin's Lymphoma or Chronic Lyphocytic LeukemiaEUCTR2008-000434-47-FRImmunomedics, Inc.46
Unknown
Phase 1
Phase I/II study of adoptive immunotherapy using predetermined minor histocompatibility antigen-specific cytotoxic T cells for patients with high-risk leukemia that relapsed following allogeneic hematopoietic stem cell transplantation.1) RAEB, CMML 2) AML or ALL in induction failure or beyond first remission 3) Ph/p190-positive ALL at any stage 4) imatinib-resistant CMJPRN-C000000161Aichi Cancer Center30